Monday, December 23, 2024 | 07:53 AM ISTEN Hindi

Home / Content / B2B Connect / Pharma / Initiatives to promote healthcare R&D is missing in budget: Dr KM Cherian

Initiatives to promote healthcare R&D is missing in budget: Dr KM Cherian

Lagging behind in biosciences is not good for social security and strategic national security

Premium

Dr K M Cherian, chairman and CEO, Frontier Lifeline Hospital

BS B2B Bureau Chennai

Last Updated : Feb 02 2017 | 11:30 AM IST

The current budget is a good attempt for overall development of the country. However, as a senior healthcare professional in the country, I would have been happier to see some budget initiatives for promoting healthcare R&D.

Nearly 40 percent of global academic papers in bioscience and technology comes from Asia, led by China which is forecast to overtake the US as a producer of academic papers by 2020. In terms of PPP adjusted R&D spending, US leads the world with $ 473 billion (2.7 percent GDP PPP) followed by China, spending $ 409 billion (2.1 percent). The number of papers authored

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in